UroGen Pharma (URGN) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: URGN) | Delayed: 34.28 -0.08 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.36 | 52 Week High | $ | |||
| Open | $34.50 | 52 Week Low | $ | |||
| Day High | $34.93 | P/E | N/A | |||
| Day Low | $34.00 | EPS | $ | |||
| Volume | 141,273 | |||||
